171 related articles for article (PubMed ID: 21242968)
1. c-Cbl inhibits angiogenesis and tumor growth by suppressing activation of PLCγ1.
Meyer RD; Husain D; Rahimi N
Oncogene; 2011 May; 30(19):2198-206. PubMed ID: 21242968
[TBL] [Abstract][Full Text] [Related]
2. Role of c-Cbl-dependent regulation of phospholipase Cgamma1 activation in experimental choroidal neovascularization.
Husain D; Meyer RD; Mehta M; Pfeifer WM; Chou E; Navruzbekov G; Ahmed E; Rahimi N
Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6803-9. PubMed ID: 20592236
[TBL] [Abstract][Full Text] [Related]
3. A critical role for the E3-ligase activity of c-Cbl in VEGFR-2-mediated PLCgamma1 activation and angiogenesis.
Singh AJ; Meyer RD; Navruzbekov G; Shelke R; Duan L; Band H; Leeman SE; Rahimi N
Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5413-8. PubMed ID: 17372230
[TBL] [Abstract][Full Text] [Related]
4. A role for protein ubiquitination in VEGFR-2 signalling and angiogenesis.
Rahimi N
Biochem Soc Trans; 2009 Dec; 37(Pt 6):1189-92. PubMed ID: 19909244
[TBL] [Abstract][Full Text] [Related]
5. c-Cbl: An Important Regulator and a Target in Angiogenesis and Tumorigenesis.
Lyle CL; Belghasem M; Chitalia VC
Cells; 2019 May; 8(5):. PubMed ID: 31126146
[TBL] [Abstract][Full Text] [Related]
6. IQGAP1-dependent signaling pathway regulates endothelial cell proliferation and angiogenesis.
Meyer RD; Sacks DB; Rahimi N
PLoS One; 2008; 3(12):e3848. PubMed ID: 19050761
[TBL] [Abstract][Full Text] [Related]
7. Recruitment and activation of phospholipase Cgamma1 by vascular endothelial growth factor receptor-2 are required for tubulogenesis and differentiation of endothelial cells.
Meyer RD; Latz C; Rahimi N
J Biol Chem; 2003 May; 278(18):16347-55. PubMed ID: 12598525
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor (VEGF) receptor-2 tyrosine 1175 signaling controls VEGF-induced von Willebrand factor release from endothelial cells via phospholipase C-gamma 1- and protein kinase A-dependent pathways.
Xiong Y; Huo Y; Chen C; Zeng H; Lu X; Wei C; Ruan C; Zhang X; Hu Z; Shibuya M; Luo J
J Biol Chem; 2009 Aug; 284(35):23217-24. PubMed ID: 19570985
[TBL] [Abstract][Full Text] [Related]
9. NDRG1 activates VEGF-A-induced angiogenesis through PLCγ1/ERK signaling in mouse vascular endothelial cells.
Watari K; Shibata T; Fujita H; Shinoda A; Murakami Y; Abe H; Kawahara A; Ito H; Akiba J; Yoshida S; Kuwano M; Ono M
Commun Biol; 2020 Mar; 3(1):107. PubMed ID: 32144393
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor-dependent down-regulation of Flk-1/KDR involves Cbl-mediated ubiquitination. Consequences on nitric oxide production from endothelial cells.
Duval M; Bédard-Goulet S; Delisle C; Gratton JP
J Biol Chem; 2003 May; 278(22):20091-7. PubMed ID: 12649282
[TBL] [Abstract][Full Text] [Related]
11. Caveolin-1 regulates VEGF-stimulated angiogenic activities in prostate cancer and endothelial cells.
Tahir SA; Park S; Thompson TC
Cancer Biol Ther; 2009 Dec; 8(23):2286-96. PubMed ID: 19923922
[TBL] [Abstract][Full Text] [Related]
12. Binding of Cbl to a phospholipase Cgamma1-docking site on platelet-derived growth factor receptor beta provides a dual mechanism of negative regulation.
Reddi AL; Ying G; Duan L; Chen G; Dimri M; Douillard P; Druker BJ; Naramura M; Band V; Band H
J Biol Chem; 2007 Oct; 282(40):29336-47. PubMed ID: 17620338
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor stimulates a novel calcium-signaling pathway in vascular smooth muscle cells.
Chandra A; Angle N
Surgery; 2005 Oct; 138(4):780-7. PubMed ID: 16269309
[TBL] [Abstract][Full Text] [Related]
14. Essential role of calcium in vascular endothelial growth factor A-induced signaling: mechanism of the antiangiogenic effect of carboxyamidotriazole.
Faehling M; Kroll J; Föhr KJ; Fellbrich G; Mayr U; Trischler G; Waltenberger J
FASEB J; 2002 Nov; 16(13):1805-7. PubMed ID: 12354692
[TBL] [Abstract][Full Text] [Related]
15. A dynamic constitutive and inducible binding of c-Cbl by PLCgamma1 SH3 and SH2 domains (negatively) regulates antigen receptor-induced PLCgamma1 activation in lymphocytes.
Rellahan BL; Graham LJ; Tysgankov AY; DeBell KE; Veri MC; Noviello C; Bonvini E
Exp Cell Res; 2003 Sep; 289(1):184-94. PubMed ID: 12941616
[TBL] [Abstract][Full Text] [Related]
16. C-CBL is required for inhibition of angiogenesis through modulating JAK2/STAT3 activity in ROP development.
Chen S; Sun Q; Sun D; Willette-Brown J; Anderson MJ; Gu Q; Lewandoski M; Hu Y; Zhu F; Wei F; Zhang J
Biomed Pharmacother; 2020 Dec; 132():110856. PubMed ID: 33125970
[TBL] [Abstract][Full Text] [Related]
17. Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses.
Slevin M; Kumar S; Gaffney J
J Biol Chem; 2002 Oct; 277(43):41046-59. PubMed ID: 12194965
[TBL] [Abstract][Full Text] [Related]
18. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
[TBL] [Abstract][Full Text] [Related]
19. Heterotrimeric G alpha q/G alpha 11 proteins function upstream of vascular endothelial growth factor (VEGF) receptor-2 (KDR) phosphorylation in vascular permeability factor/VEGF signaling.
Zeng H; Zhao D; Yang S; Datta K; Mukhopadhyay D
J Biol Chem; 2003 Jun; 278(23):20738-45. PubMed ID: 12670961
[TBL] [Abstract][Full Text] [Related]
20. Cbl-b is a negative regulator of inflammatory cytokines produced by IgE-activated mast cells.
Gustin SE; Thien CB; Langdon WY
J Immunol; 2006 Nov; 177(9):5980-9. PubMed ID: 17056522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
